145
edits
Changes
no edit summary
| info =
* Citalopram is a weak inhibitor of CYP2D6, which metabolizes vortioxeine.
* {{theorSS}}Patients could be directly switched from a SSRI or a SNRI to vortioxetine 10 mg/day. One week after intiation with vortioxetine, the dosage could be increased from 10 mg/day to 20 mg/day.<ref>[[European Medicines Agency]] | SmPC Brintellix http://www.ncbi.nlm.nih.gov/pubmed/25087600 Montgomery SA et al. A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine. Hum Psychopharmacol. 2014 Sep;29(5 mg):470-82. ]</ref>
}}
